{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:13:10Z","timestamp":1789578790409,"version":"build-2803163510"},"reference-count":22,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>We report on a 66-year-old man who presented with a right axillary lymphadenopathy approximately 10 days after receiving the third dose of the BNT162b2 vaccine. The lymphadenopathy gradually enlarged, and physical examination and ultrasound (US) revealed one right axillary 6.99 cm and one right supraclavicular 2.36 cm lymphadenopathy. Histologic examination of the right axillary nodule revealed anaplastic large-cell lymphoma that was ALK negative and CD30 positive. A total body computerized tomography (CT) scan, positron emission tomography (PET) and bone-marrow biopsy showed a stage-II non-Hodgkin lymphoma (NHL). The patient was treated with chemotherapy and a scheme of Brentuximab Vedotin, Cyclophosphamide, Doxorubicin and Prednisone (BV-CHP) for six cycles and is now well and in complete remission. The revision of the literature revealed eight additional cases of NHL developed shortly after COVID-vaccination. There were four cases of diffuse large-B-cell lymphoma (DLBCL) (one in a patient who was a heart transplant recipient and developed an Epstein\u2013Bar-virus-positive DLBCL), one case of extranodal NK\/T-cell lymphoma, one patient with subcutaneous panniculitis-like T-cell lymphoma, one case of marginal zone B-cell lymphoma and one primary cutaneous anaplastic large-cell lymphoma (PC-ALCL). In five cases, the lymphoma developed after BNT162b2 mRNA vaccination, including one case after ChAdOx1 nCOV-19, one case after the adenovirus type 26 (Ad26) vaccine and one after mRNA-1273\/Spikevax (ModernaTX). We are aware that the link between COVID-19 vaccination and lymphoma most likely is a chance phenomenon, and that COVID-19 vaccines represent very efficient products for many people around the world. However, we believe that clinical events, even if only temporally associated with novel treatments or novel vaccines, should be reported for the benefit of the patients and the scientific community.<\/jats:p>","DOI":"10.3390\/medicina59010157","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T02:05:52Z","timestamp":1673575552000},"page":"157","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Non-Hodgkin Lymphoma Developed Shortly after mRNA COVID-19 Vaccination: Report of a Case and Review of the Literature"],"prefix":"10.3390","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0303-3778","authenticated-orcid":false,"given":"Luigi","family":"Cavanna","sequence":"first","affiliation":[{"name":"Department of Oncology and Hematology, ASL Piacenza, Via Taverna 49, 29121 Piacenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio Ottavio","family":"Grassi","sequence":"additional","affiliation":[{"name":"ASST Lodi, 26900 Lodi, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4398-8368","authenticated-orcid":false,"given":"Livia","family":"Ruffini","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Division, Azienda Ospedaliero-Universitaria di Parma, 43126 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Michieletti","sequence":"additional","affiliation":[{"name":"Department of Radiology, ASL Piacenza, Via Taverna 49, 29121 Piacenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egidio","family":"Carella","sequence":"additional","affiliation":[{"name":"Department of Radiology, ASL Piacenza, Via Taverna 49, 29121 Piacenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dante","family":"Palli","sequence":"additional","affiliation":[{"name":"Surgey and Breast Unit, Guglielmo da Saliceto Hospital, Via Taverna 49, 29121 Piacenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Zangrandi","sequence":"additional","affiliation":[{"name":"Pathology Unit, ASL Piacenza, Via Taverna 49, 29121 Piacenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Inzerilli","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hematology, ASL Piacenza, Via Taverna 49, 29121 Piacenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Bernuzzi","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hematology, ASL Piacenza, Via Taverna 49, 29121 Piacenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Di Nunzio","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hematology, ASL Piacenza, Via Taverna 49, 29121 Piacenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Citterio","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hematology, ASL Piacenza, Via Taverna 49, 29121 Piacenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/1097-0142(196804)21:4<632::AID-CNCR2820210415>3.0.CO;2-O","article-title":"Postvaccinial lymphadenitis. Hyperplasia of lymphoid tissue that simulates malignant lymphomas","volume":"21","author":"Hartsock","year":"1968","journal-title":"Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1592\/phco.28.9.1194","article-title":"Development of unilateral cervical and supraclavicular lymphadenopathy after human papillomavirus vaccination","volume":"28","author":"Studdiford","year":"2008","journal-title":"Pharmacotherapy"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Centers for Disease Control and Prevention (2022, December 10). Local Reactions, Systemic Reactions, Adverse Events, and Serious Adverse Events: Pfizer-BioNTech COVID-19 Vaccine, Available online: https:\/\/www.cdc.gov\/vaccines\/covid-19\/info-by-product\/pfizer\/reactogenicity.html.","DOI":"10.3390\/vaccines10020233"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"E323","DOI":"10.1148\/radiol.2021210436","article-title":"Multidisciplinary recommendations regarding post-vaccine adenopathy and radiologic imaging: Radiology scientific expert panel","volume":"300","author":"Becker","year":"2021","journal-title":"Radiology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.25259\/Cytojournal_21_2021","article-title":"Cytologic and histologic features of COVID-19 post-vaccination lymphadenopathy","volume":"18","year":"2021","journal-title":"Cytojournal"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e613","DOI":"10.1111\/jdv.18136","article-title":"Two cases of axillary lymphadenopathy diagnosed as diffuse large B-cell lymphoma developed shortly after BNT162b2 COVID-19 vaccination","volume":"36","author":"Mizutani","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Zamfir, M.A., Moraru, L., Dobrea, C., Scheau, A.E., Iacob, S., Moldovan, C., Cristian Scheau, C., Caruntu, C., and Caruntu, A. (2022). Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases. Medicina, 58.","DOI":"10.3390\/medicina58070874"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.transproceed.2021.09.006","article-title":"A Case Report of Posttransplant Lymphoproliferative Disorder after AstraZeneca Coronavirus Disease 2019 Vaccine in a Heart Transplant Recipient","volume":"54","author":"Tang","year":"2022","journal-title":"Transplant. Proc."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jdcr.2022.08.006","article-title":"Subcutaneous panniculitis-like T-cell lymphoma after COVID-19 vaccination","volume":"28","author":"Kreher","year":"2022","journal-title":"JAAD Case Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"963393","DOI":"10.3389\/fmed.2022.963393","article-title":"Rapid progression of marginal zone B-cell lymphoma after COVID-19 vaccination (BNT162b2): A case report","volume":"9","author":"Sekizawa","year":"2022","journal-title":"Front. Med."},{"key":"ref_11","first-page":"e32","article-title":"Anaplastic large cell lymphoma at the SARS-CoV2 vaccine injection site","volume":"37","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.clinimag.2021.01.016","article-title":"Unilateral axillary lymphadenopathy in the setting of COVID-19 vaccine","volume":"75","author":"Mehta","year":"2021","journal-title":"Clin. Imaging"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.3348\/kjr.2021.0350","article-title":"COVID-19 Vaccine-Related Axillary and Cervical Lymphadenopathy in Patients with Current or Prior Breast Cancer and Other Malignancies: Cross-Sectional Imaging Findings on MRI, CT, and PET-CT","volume":"22","author":"Lane","year":"2021","journal-title":"Korean J. Radiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"E280","DOI":"10.1148\/radiol.2021210236","article-title":"Adenopathy following COVID19 vaccination","volume":"299","author":"Washington","year":"2021","journal-title":"Radiology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jacr.2021.03.001","article-title":"Unilateral Lymphadenopathy after COVID-19 Vaccination: A Practical Management Plan for Radiologists Across Specialties","volume":"18","author":"Lehman","year":"2021","journal-title":"J. Am. Coll. Radiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"798095","DOI":"10.3389\/fmed.2021.798095","article-title":"Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report","volume":"8","author":"Goldman","year":"2021","journal-title":"Front. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/jha2.268","article-title":"Hypermetabolic lymphadenopathy on positron emission tomography scan following COVID-19 vaccination: A mimicker of disease progression in Hodgkin lymphoma","volume":"2","author":"Suleman","year":"2021","journal-title":"eJHaem"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/jha2.297","article-title":"Axillary lymph nodes on PET in Hodgkin lymphoma after COVID-19 vaccination","volume":"2","author":"Arens","year":"2021","journal-title":"eJHaem"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/RLU.0000000000003597","article-title":"COVID-19 mRNA Vaccination-Induced Lymphadenopathy Mimics Lymphoma Progression on FDG PET\/CT","volume":"46","author":"Xu","year":"2021","journal-title":"Clin. Nucl. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1080\/21645515.2021.2008215","article-title":"Hypermetabolic abdominal and cervical lymph nodes mimicking Hodgkin lymphoma relapse on FDG PET\/CT after adenovirus-vectored COVID-19 vaccine","volume":"17","author":"Landete","year":"2021","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e004371","DOI":"10.1136\/jitc-2021-004371","article-title":"Spontaneous tumor regression following COVID-19 vaccination","volume":"10","author":"Sousa","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/bjd.20630","article-title":"Primary cutaneous anaplastic large-cell lymphoma with marked spontaneous regression of organ manifestation after SARS-CoV-2 vaccination","volume":"185","author":"Gambichler","year":"2021","journal-title":"Br. J. Dermatol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/1\/157\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:04:42Z","timestamp":1760119482000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/1\/157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,12]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["medicina59010157"],"URL":"https:\/\/doi.org\/10.3390\/medicina59010157","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,12]]}}}